RayOne Galaxy; Model RAO605G, RayOne Galaxy Toric; Model RAO615X
Rayner Intraocular Lenses , Ltd. · Decision date Sep 24, 2026
What did the FDA approve?
FDA records P060011/S045 as a supplement to PMA P060011, with the supplement type “Panel Track”. The recorded decision is approval, dated Sep 24, 2026.
FDA approval order statement
Approval for the RayOne Galaxy (RAO605G) and the RayOne Galaxy Toric (RAO615X). RayOne Galaxy (Model RAO605G) is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia, in adult patients in whom a cataractous lens has been removed.The IOL mitigates the effects of presbyopia by providing improved intermediate and near visual acuity while maintaining comparable distance visual acuity to a monofocal IOL.RayOne Galaxy is intended for implantation in patients with less than 1.00 diopter of pre-existing corneal astigmatism. The RayOne injection system is used to fold and assist in inserting the IOL into the eye.RayOne Galaxy Toric (Model RAO615X) is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia, in adult patients in whom a cataractous lens has been removed.The IOL mitigates the effects of presbyopia by providing improved intermediate and near visual acuity while maintaining comparable distance visual acuity to a monofocal IOL.In addition, RayOne Galaxy Toric is intended to provide reduction of residual refractive astigmatism in patients with corneal astigmatism greater than or equal to 1.03 diopter, up to 3.07 diopter. The RayOne injection system is used to fold and assist in inserting the IOL into the eye.
- Regulatory pathway
- PMA supplement
- Supplement type
- Panel Track
- Clinical specialty
- Ophthalmic
- Decision date
- Sep 24, 2026
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P060011/S045
- Regulatory pathway
- PMA supplement
- Applicant
- Rayner Intraocular Lenses , Ltd.
- Product code
- MFK
- Decision code
- APPR
- Decision date
- Sep 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lens, multifocal intraocular.
- Applicant
- Rayner Intraocular Lenses , Ltd.
- Product code
- MFK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P060011. Subsequent supplements may change the device or its indications.
FDA decision timeline
P060011 · Original PMA
C-FLEX MODEL 570C INTRAOCULAR LENS (IOL)
P060011/S045 received
Application receipt date recorded by FDA.
P060011/S045 · FDA decision
Panel Track
Timeline entries are records held by MedtechLedger for P060011. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060011
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Rayner Intraocular Lenses , Ltd. | PMA approval | May 3, 2007 | FDA |
Explore the linked device profile
Other records with product code MFK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ClearView HD intraocular lens (IOL)P200020/S013 | Lenstec, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA | |
TECNIS Multi-focal 3-pc, Model ZMA00P080010/S032 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA |
| Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Bausch + Lomb, Inc. | PMA supplement | Sep 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Rayner Intraocular Lenses , Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1-2 Sackville Trading Estate,, Sackville Rd., Hove, E. Sussex, BN3 7AN
Sources and methodology
- Original FDA record: P060011/S045
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


